Quantum BioPharma News - September 9, 2026
Quantum BioPharma's FDA Green Light for Its MS Drug Sparks a Rally — But Can a $22 Million Company Really Crack a $38 Billion Market?
Shares of Quantum BioPharma (NASDAQ: QNTM) surged as much as 10.6% to $3.64 on September 9 — bucking a down market — after fresh coverage highlighted the FDA's...
🟢 Quantum BioPharma is trading 10.64% up today after FDA clearance for Lucid-MS Phase 2 testing
Quantum BioPharma is trading 10.64% up now at $3.64 after September 9, 2026 coverage spotlighted FDA clearance for Lucid-MS to enter Phase 2 testing in...
🟢 Quantum BioPharma is trading 5.78% up today after FDA-clearance coverage of Lucid-MS Phase 2 trials
Quantum BioPharma is trading 5.78% up now at $3.48 after September 9, 2026 coverage highlighted FDA clearance to begin Phase 2 trials of Lucid-MS, its...